The first patient has been dosed in a China-based Phase 1/2a clinical trial testing YOLT-201, Yoltech Therapeutics’ one-time gene-editing…
Articles by Margarida Maia, PhD
The oral medication tafamidis meglumine appears to be well tolerated by adults with familial amyloid polyneuropathy (FAP) in…
Getting genetic counseling can encourage people at risk for hereditary transthyretin amyloidosis to have genetic testing and know they have…
Rising levels of a protein called neurofilament light chain (NfL) in the blood may indicate nerve damage due to…
Tegsedi (inotersen) safely and effectively slowed the progression of polyneuropathy, or damage to multiple nerves, when taken for up…
The parameters of muscle ultrasound, which uses sound waves to make pictures of muscles, are significantly different among people with…
A study of people carrying mutations known to cause familial amyloid polyneuropathy (FAP) found that those with disease symptoms…
Abnormalities in capillaries, or very small blood vessels, and inflammation from increased blood clotting may contribute to nerve damage, or…
Running a genetic screening may help to diagnose familial amyloid polyneuropathy (FAP) among people with sensory-motor polyneuropathy — damage…
New 15-year data from a global study involving more than 6,000 people with ATTR amyloidosis, an umbrella term for conditions…